Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Operating Leases (2018 - 2026)

Kamada's (KMDA) quarterly Operating Leases came in at $9.5 million in Q2 2026, little changed on a YoY basis from $9.5 million in Q2 2025, and up 0.76% quarter-over-quarter from $9.4 million in Q1 2026.

Analysis

Kamada (KMDA) Operating Leases (2018 - 2026) Analysis & Trends

Kamada (KMDA) has reported Operating Leases for 9 consecutive years, with $9.5 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Operating Leases changed 0.36% year-over-year to $9.5 million; the trailing twelve-month figure through Jun 2026 stood at $9.5 million (changed 0.36% YoY), and the FY2025 full-year result was $9.4 million, changed 0.1% from the prior year.
  • Operating Leases rose to $9.5 million in Q2 2026 per KMDA's latest filing, from $9.4 million in the prior quarter.
  • Across five years, Operating Leases topped out at $9.6 million in Q3 2024 and bottomed at $2.2 million in Q4 2022.
  • Historically, Operating Leases has averaged $6.8 million across 5 years, with a median of $7.4 million in 2023.
  • The sharpest annual moves came in 2022 and 2023: Operating Leases slumped 31.11% in 2022, then jumped 241.66% in 2023.
  • Over 5 years, Operating Leases stood at $2.2 million in 2022, then surged by 241.66% to $7.4 million in 2023, then climbed by 26.79% to $9.4 million in 2024, then advanced by 0.1% to $9.4 million in 2025, then rose by 0.79% to $9.5 million in 2026.
  • According to Business Quant data, Operating Leases over the past three periods registered $9.5 million, $9.4 million, and $9.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Kamada 473.57 Mn 403.43 Mn 22.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.52 Mn
Mar 31, 2026 9.44 Mn
Dec 31, 2025 9.44 Mn
Sep 30, 2025 9.56 Mn
Jun 30, 2025 9.55 Mn
Mar 31, 2025 9.32 Mn
Dec 31, 2024 9.43 Mn
Sep 30, 2024 9.57 Mn
Jun 30, 2024 7.07 Mn
Mar 31, 2024 7.28 Mn
Dec 31, 2023 7.44 Mn
Sep 30, 2023 4.72 Mn
Jun 30, 2023 4.97 Mn
Mar 31, 2023 4.99 Mn
Dec 31, 2022 2.18 Mn
Sep 30, 2022 2.41 Mn
Jun 30, 2022 2.49 Mn
Mar 31, 2022 3.06 Mn
Dec 31, 2021 3.16 Mn
Sep 30, 2021 3.28 Mn